Cool W P, Carter S R, Grimer R J, Tillman R M, Walker P S
Royal Orthopaedic Hospital, Northfield, Birmingham, England, UK.
J Bone Joint Surg Br. 1997 Nov;79(6):938-42. doi: 10.1302/0301-620x.79b6.7868.
We report our results in 24 children with malignant primary bone tumours of the distal femur treated with a Stanmore extendible endoprosthesis (SEER). This consists of a femoral component that can be lengthened, a constrained knee and an uncemented sliding tibial component which crosses the proximal tibial physeal plate perpendicularly. The average age of the patients at diagnosis was ten years and the mean follow-up was 4.7 years (2.5 to 7.9). The mean growth of the affected tibia was 76% (18 to 136) and of the fibula 83% (15 to 750) of the growth of the unaffected limb. Measurement of growth arrest lines showed that the mean growth of the proximal tibial physis on the affected side was 69% (43 to 100) of that of the normal side. The great variability in the growth of the physis cannot yet be explained.
我们报告了24例采用斯坦莫尔可延长假体（SEER）治疗的股骨远端原发性恶性骨肿瘤患儿的结果。该假体包括一个可延长的股骨组件、一个限制性膝关节和一个非骨水泥型滑动胫骨组件，该胫骨组件垂直穿过胫骨近端骨骺板。患者诊断时的平均年龄为10岁，平均随访时间为4.7年（2.5至7.9年）。患侧胫骨的平均生长量为健侧肢体生长量的76%（18%至136%），腓骨为83%（15%至750%）。生长停滞线测量显示，患侧胫骨近端骨骺的平均生长量为正常侧的69%（43%至100%）。骨骺生长的巨大变异性尚无法解释。
